3 weeks 3 Monster Biotech Stocks to Buy Before 2025 Yahoo Finance 3 Monster Biotech Stocks to Buy Before 2025. Biotech · Biotech Stocks
8 hours Hedge Fund and Insider Trading News: Chris Hansen, David Tepper, Paul Singer, Steven Cohen, Platinum Asset Management, Elliott Investment Management, Millennium Management, Fortress Biotech Inc (FBIO), Crowdstrike Holdings Inc (CRWD), and MoreInsider Monkey
16 hours Novo Nordisk’s $600 Million Gambit Could Be a Game Changer for the Stock. Here’s Why.The Motley Fool
16 hours A surfer without a degree is worth $16 billion after his biotech company’s stock soared 1,100% in a yearBusiness Insider
2 days Wave Life Sciences’ stock soars 51% after biotech posts positive data from Duchenne muscular-dystrophy trialMarketWatch
3 days Tesla Leads S&P 500 Index, While Biotech Giant Tumbles On Court RulingInvestor's Business Daily
1 week GeneDx Stock Rocketed 1310% In Dramatic Turnaround Powered By DNA AnalyticsInvestor's Business Daily
1 week Is It Too Late to Buy Summit Therapeutics Stock After Its Almost 10X Gain This Year?The Motley Fool
1 week Legend Biotech: Entering Accelerated Growth Phase, Carvykti Positions Company For Valuation ExpansionSeeking Alpha
1 week How BioNTech, Up 26% Over Four Days, Is Riding Summit’s Coattails To A RecoveryInvestor's Business Daily
1 week Nuvalent Flies On ‘Multibillion-Dollar’ Potential, While Iteos Crashes On Patient DeathsInvestor's Business Daily
2 weeks Down More Than 50%, Is It Time to Buy Moderna Stock as the Biotech Charts a New Post-COVID Path?The Motley Fool
2 weeks Missed Out on Viking Therapeutics? Buy This Weight Loss Biotech Stock Right Now.The Motley Fool
2 weeks Investing in Biotech or Pharma Stocks? Pay Attention to These 3 Things and You’ll Win MoreThe Motley Fool
2 weeks Gilead Sciences Pops On A New $4 Billion Opportunity In HIV PreventionInvestor's Business Daily
2 weeks The Brawl Taking Shape Over Pfizer’s Multibillion-Dollar Heart MonopolyThe Wall Street Journal
2 weeks Terns Pharmaceuticals’ stock soars 17% after biotech posts positive results in trial of weight-loss drug in pill formMarketWatch
3 weeks Summit Therapeutics’ stock pops as lung-cancer treatment beats Merck blockbuster in late-stage trialMarketWatch
3 weeks Alnylam Pharmaceuticals, Inc. (ALNY): Do Hedge Funds Recommend This Biotech Stock Now?Insider Monkey
3 weeks Regeneron Pharmaceuticals, Inc. (REGN): The Best Biotech Stock According to Hedge Funds?Insider Monkey
3 weeks Vertex Pharmaceuticals Incorporated (VRTX): Why Do Hedge Funds Recommend This Biotech Stock?Insider Monkey
3 weeks Is Cytokinetics, Incorporated (CYTK) a Good Biotech Stock According to Hedge Funds?Insider Monkey
3 weeks Insmed Incorporated (INSM): Hedge Funds Are Recommending This Biotech Stock NowInsider Monkey
3 weeks Jazz Pharmaceuticals plc (JAZZ): Why Do Hedge Funds Recommend This Biotech Stock?Insider Monkey
3 weeks Travere Stock Pops After Snagging Full Approval For Calliditas Rival In Kidney DiseaseInvestor's Business Daily
3 weeks Down a Monstrous 90% This Year, Is There Any Hope Left for Ginkgo Bioworks Investors?The Motley Fool
3 weeks Prediction: This Biotech Stock Will Outperform Nvidia in the Second Half of the YearYahoo Finance
3 weeks Vaxcyte Catapults As It Looks To Take On Pfizer, Merck In A Massive MarketInvestor's Business Daily
4 weeks Emergent BioSolutions’ stock soars 23% after FDA approves its smallpox vaccine for mpoxMarketWatch
4 weeks A futurist explains 3 essential things needed to prepare for the imminent AI and biotech revolutionsFast Company
1 month 3 Ways the Democratic Party’s Platform Could Impact Biotech and Pharma Stocks if ImplementedThe Motley Fool
1 month Why This Rival To Gilead, Novartis Just Jumped 10% — And Why There Are CaveatsInvestor's Business Daily
1 month Top VC explains why he thinks the sky-high valuations of AI companies aren’t justified, predicts ‘a lot of destruction’Business Insider